Noncolorectal Gastrointestinal Cancer Journal Articles

• Metastasis in Patients With Hepatocellular Carcinoma This authors investigated the prevalence, associated factors, and prognostic impact of metastasis in hepatocellular carcinoma, proposing a modified BCLC system based on metastasis.
  Liver International, November 2018
• Liver Fat Scores Predict Liver Disease Mortality in the US This study examined how markers of liver health are associated with mortality in persons without viral hepatitis in the United States. Are liver fat scores useful for metabolic health surveillance?
  Alimentary Pharmacology & Therapeutics, November 2018
• Drug-induced Liver Injury in the Context of NAFLD How might certain drugs be more hepatotoxic in NAFLD patients? This article explores the pathophysiological mechanisms and reciprocity involved in NAFLD and drug-induced steatohepatitis.
  Alimentary Pharmacology & Therapeutics, November 2018
• Nutritional Support in Surgery for Abdominal Malignancies Might perioperative nutritional support using this compound help reduce wound complications after surgery for abdominal malignancies?
  Wounds, November 2018
• DTI + MRS to Predict Neurological Outcome Before TIPSS How might multimodal MRI imaging be used to determine patients at risk of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt placement?
  Alimentary Pharmacology & Therapeutics, November 2018
• Early Development of De Novo HCC After DAA Therapy The results of this study indicate that chronic HCV patients treated either with PegIFN or an all-oral DAA regimen remain at risk for development of de novo hepatocellular carcinoma.
  Journal of Viral Hepatitis, October 2018
• Benefits From Oncology Drugs in Older vs Younger Patients Should age be a deciding factor when making treatment decisions for older cancer patients? This review examined whether novel oncology drugs provide different outcomes for older vs. younger patients.
  Age and Ageing, October 2018
• Tildrakizumab for Moderate-to-Severe Plaque Psoriasis Is tildrakizumab therapy a safe and effective treatment option for moderate-to-severe plaque psoriasis?
  The British Journal of Dermatology, October 2018
• Adverse Effects of PPIs: Fact or Fake News? Recent media reports have ascribed serious adverse effects to proton pump inhibitors, raising concerns in both patients and providers. Is there good clinical evidence to back up these assertions?
  Current Opinion in Gastroenterology, October 2018
• Risk of HCC in NASH Compared to Other Liver Diseases What is the pooled risk of hepatocellular carcinoma, as compared to other liver diseases, in patients with NASH with and without cirrhosis?
  Alimentary Pharmacology & Therapeutics, October 2018
• Risk Factors of HCC After HBsAg Seroclearance Which factors might increase risk of hepatocellular carcinoma among patients with chronic hepatitis B who have achieved seroclearance of hepatitis B surface antigen?
  Journal of Viral Hepatitis, October 2018
• Systemic Treatment of Hepatocellular Carcinoma This review discusses the evolution of targeted therapy with tyrosine kinase inhibitors and recent developments in immunotherapy for systemic treatment of hepatocellular carcinoma.
  Alimentary Pharmacology & Therapeutics, October 2018
• Competing Risks in Older Patients With Cancer Older patients with cancer may value quality of life and relief of symptoms more than overall survival. Are clinical trials measuring appropriate endpoints in this population?
  Journal of the National Cancer Institute, September 2018
• Feasibility and Cost-effectiveness of Reaching WHO HCV Targets This study evaluated the success and cost-effectiveness of initiatives to increase HCV treatment uptake and interventions for reducing the incidence of new infection among injection drug users.
  Journal of Viral Hepatitis, September 2018
• Reducing Risk of Esophageal Cancer in Barrett's Esophagus Patients with Barrett's esophagus have a high risk of developing esophageal adenocarcinoma. Can PPIs and H2 receptor antagonists mitigate the risk?
  Alimentary Pharmacology & Therapeutics, September 2018
• Association Between PPIs and Hepatocellular Carcinoma Might long-term use of proton pump inhibitors increase the risk of hepatocellular carcinoma?
  Alimentary Pharmacology & Therapeutics, September 2018
• Hepatitis B Virus and Risk of Non-Hodgkin Lymphoma Several prior studies have suggested that chronic HBV infection can increase the risk of non-Hodgkin's lymphoma. What's the current best evidence on this possible relationship?
  Journal of Viral Hepatitis, September 2018
• Circulating Tumor Cell Dynamics in Pancreatic Adenocarcinoma What is the clinical significance of circulating tumor cells in pancreatic ductal adenocarcinoma?
  Annals of Surgery, September 2018
• Sonographic Presentation of Metastases to the Thyroid Gland These cases highlight the role of sonography in the assessment of metastatic thyroid nodules.
  Journal of the Endocrine Society, September 2018
• Manual vs Automated Squamous Cell Carcinoma Antigen Assays Does the automated Elecsys SCC assay provide comparable performance to a manual assay for determining squamous cell carcinoma antigen levels?
  Laboratory Medicine, September 2018